Akanda Corp (NASDAQ:AKAN) — Market Cap & Net Worth
Market Cap & Net Worth: Akanda Corp (AKAN)
Akanda Corp (NASDAQ:AKAN) has a market capitalization of $2.84 Million ($2.84 Million) as of August 3, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #29544 globally and #5948 in its home market, demonstrating a -34.20% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Akanda Corp's stock price $5.31 by its total outstanding shares 534418 (534.42K). Review Akanda Corp debt and liabilities to assess the company's total debt and financial obligations.
Akanda Corp Market Cap History: 2022 to 2026
Akanda Corp's market capitalization history from 2022 to 2026. Data shows change from $63.70 Million to $2.84 Million (-81.39% CAGR).
Index Memberships
Akanda Corp is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.46 Trillion | 0.00% | #869 of 976 |
|
NASDAQ Composite
IXIC
|
$40.26 Trillion | 0.00% | #2753 of 3165 |
Weight: Akanda Corp's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Akanda Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Akanda Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.95x
Akanda Corp's market cap is 0.95 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $63.70 Million | $2.62 Million | -$11.66 Million | 24.32x | N/A |
| 2023 | $18.83 Million | $2.16 Million | -$32.28 Million | 8.72x | N/A |
| 2024 | $855.07K | $836.66K | -$4.10 Million | 1.02x | N/A |
| 2025 | $244.39K | $258.07K | -$45.65 Million | 0.95x | N/A |
Competitor Companies of AKAN by Market Capitalization
Companies near Akanda Corp in the global market cap rankings as of August 3, 2026.
Key companies related to Akanda Corp by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #503 globally with a market cap of $52.60 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #528 globally with a market cap of $50.48 Billion USD ( CN¥344.98 Billion CNY).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #550 globally with a market cap of $48.78 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #619 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #503 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #528 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $50.48 Billion | CN¥54.08 |
| #550 | GALDERMA GROUP AG | NYSE:GALDY | $48.78 Billion | $43.60 |
| #619 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €15.50 |
Akanda Corp Historical Marketcap From 2022 to 2026
Between 2022 and today, Akanda Corp's market cap moved from $63.70 Million to $ 2.84 Million, with a yearly change of -81.39%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $2.84 Million | +1061.16% |
| 2025 | $244.39K | -71.42% |
| 2024 | $855.07K | -95.46% |
| 2023 | $18.83 Million | -70.44% |
| 2022 | $63.70 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 2nd, 2026 the market cap of Akanda Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.84 Million USD |
| MoneyControl | $2.84 Million USD |
| MarketWatch | $2.84 Million USD |
| marketcap.company | $2.84 Million USD |
| Reuters | $2.84 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Akanda Corp
As of August 21, 2025, Akanda Corp. was acquired by First Towers & Fiber Corp., in a reverse merger transaction. Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis-based products. The company was incorporated in 2021 and is headquartered in Toronto, Canada.